Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.
Liver Tumors
DRUG: Definity®
adverse events, 6-weeks post surgery|identification of liver tumors, intra-operative
improved ablation of liver tumors, 6-weeks post surgery
The primary objective of this study is to demonstrate the safety of the use of intra-operative ultrasound contrast (Definity®) administration. The secondary objective of this study is to demonstrate the improved image quality and conspicuity of known liver tumors using contrast enhancement.